Healthcare >> Analyst Interviews >> June 28, 1999
PHILLIP E. NALBONE is a Managing Director and Senior Medical Technology
Analyst at Volpe Brown Whelan & Company. Previously, he was associated
with Hambrecht & Quist as a Medical Devices Analyst and with Dow Jones &
Co. as a Reporter. Mr. Nalbone graduated from St. Lawrence University
in Canton, New York. Profile
TWST: Why does it seem as if diabetes has lagged other medicalconditions and diseases as a target area, particularly given the
enormous number of people worldwide who have a form of this disease?